Sr Director, US Launch Lead — Solid Tumor

Overview A global biopharmaceutical company on a mission to Solve On, Incyte follows science to find solutions for patients with unmet medical needs. Through the discovery, development, and commercialization of proprietary therapeutics, Incyte has established a portfolio of first-in-class medicines for patients and a strong pipeline of products in Hematology, Oncology and Inflammation and Autoimmunity Headquartered in Wilmington, Delaware, Incyte has operations in North America, Europe, and Asia. Role Summary The US Launch Lead will serve as the commercial strategy and execution lead for a specific solid tumor asset anticipated to launch in approximately 18 months. This role is accountable for translating asset strategy into an integrated US launch plan, ensuring cross-functional alignment, and preparing the organization for strong in-market execution at launch. This individual will serve as a strategic bridge between R&D, Global, and US Commercial, helping to shape asset strategy, market development, and organizational readiness to maximize long-term value and ensure successful commercialization at launch and through expansion into new disease areas. The position operates in a highly matrixed environment and will lead the US launch workstream across Commercial, Market Access, Regulatory, Insights & Analytics, Sales, Training, and other enabling functions. The Launch Lead will retain core planning responsibilities while shifting emphasis from early asset assessment to near-term launch readiness, promotional strategy, launch metrics, and execution oversight.

Education Bachelor’s degree required MBA or advanced degree preferred

10+ years of progressive oncology commercial experience required, including substantial in-line marketing, brand strategy, or commercialization experience. Launch planning or launch readiness experience required. New product planning experience preferred. Experience partnering